CH629819A5 - Process for the isolation of albumin from human blood plasma - Google Patents
Process for the isolation of albumin from human blood plasma Download PDFInfo
- Publication number
- CH629819A5 CH629819A5 CH400275A CH400275A CH629819A5 CH 629819 A5 CH629819 A5 CH 629819A5 CH 400275 A CH400275 A CH 400275A CH 400275 A CH400275 A CH 400275A CH 629819 A5 CH629819 A5 CH 629819A5
- Authority
- CH
- Switzerland
- Prior art keywords
- albumin
- globulins
- blood plasma
- human blood
- isolation
- Prior art date
Links
- 102000009027 Albumins Human genes 0.000 title claims description 31
- 108010088751 Albumins Proteins 0.000 title claims description 31
- 238000000034 method Methods 0.000 title claims description 19
- 210000002381 plasma Anatomy 0.000 title claims description 8
- 238000002955 isolation Methods 0.000 title 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 15
- 239000000126 substance Substances 0.000 claims description 13
- 102000006395 Globulins Human genes 0.000 claims description 10
- 108010044091 Globulins Proteins 0.000 claims description 10
- 238000010438 heat treatment Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 108010039209 Blood Coagulation Factors Proteins 0.000 claims description 4
- 102000015081 Blood Coagulation Factors Human genes 0.000 claims description 4
- 239000003114 blood coagulation factor Substances 0.000 claims description 4
- 230000007935 neutral effect Effects 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 3
- 239000012716 precipitator Substances 0.000 claims description 3
- 239000002244 precipitate Substances 0.000 claims description 2
- 235000019441 ethanol Nutrition 0.000 claims 2
- 238000009388 chemical precipitation Methods 0.000 claims 1
- 238000010586 diagram Methods 0.000 description 7
- 239000000243 solution Substances 0.000 description 6
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 238000000760 immunoelectrophoresis Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 102000002572 Alpha-Globulins Human genes 0.000 description 2
- 108010068307 Alpha-Globulins Proteins 0.000 description 2
- 102000006734 Beta-Globulins Human genes 0.000 description 2
- 108010087504 Beta-Globulins Proteins 0.000 description 2
- 238000000665 Cohn process Methods 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 1
- 108010054218 Factor VIII Proteins 0.000 description 1
- 102000001690 Factor VIII Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102100027685 Hemoglobin subunit alpha Human genes 0.000 description 1
- 108091005902 Hemoglobin subunit alpha Proteins 0.000 description 1
- 102100021519 Hemoglobin subunit beta Human genes 0.000 description 1
- 108091005904 Hemoglobin subunit beta Proteins 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- DZTHIGRZJZPRDV-LBPRGKRZSA-N N-acetyl-L-tryptophan Chemical compound C1=CC=C2C(C[C@H](NC(=O)C)C(O)=O)=CNC2=C1 DZTHIGRZJZPRDV-LBPRGKRZSA-N 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- 102100027378 Prothrombin Human genes 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- -1 caprylate ions Chemical class 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 229940105778 coagulation factor viii Drugs 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 102000035118 modified proteins Human genes 0.000 description 1
- 108091005573 modified proteins Proteins 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical class CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 1
- 229940039716 prothrombin Drugs 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 229960005480 sodium caprylate Drugs 0.000 description 1
- BYKRNSHANADUFY-UHFFFAOYSA-M sodium octanoate Chemical compound [Na+].CCCCCCCC([O-])=O BYKRNSHANADUFY-UHFFFAOYSA-M 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
- C07K14/765—Serum albumin, e.g. HSA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2415079A DE2415079C3 (de) | 1974-03-28 | 1974-03-28 | Verfahren zum Isolieren von Albumin aus Blutplasma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH629819A5 true CH629819A5 (en) | 1982-05-14 |
Family
ID=5911480
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH400275A CH629819A5 (en) | 1974-03-28 | 1975-03-27 | Process for the isolation of albumin from human blood plasma |
Country Status (17)
| Country | Link |
|---|---|
| JP (1) | JPS5418325B2 (nl) |
| AT (1) | AT338977B (nl) |
| BE (1) | BE827050A (nl) |
| CH (1) | CH629819A5 (nl) |
| DD (1) | DD119248A5 (nl) |
| DE (1) | DE2415079C3 (nl) |
| DK (1) | DK141523C (nl) |
| EG (1) | EG11782A (nl) |
| ES (1) | ES436125A1 (nl) |
| FR (1) | FR2265757B1 (nl) |
| GB (1) | GB1480184A (nl) |
| IN (1) | IN140388B (nl) |
| NL (1) | NL177886C (nl) |
| PL (1) | PL93587B1 (nl) |
| SE (1) | SE436649B (nl) |
| SU (1) | SU743564A3 (nl) |
| ZA (1) | ZA751827B (nl) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3307871A1 (de) * | 1983-03-05 | 1984-09-13 | R & Z Biologicals S.A. (Pty.) Ltd., Cape Town | Verfahren zur gewinnung von hochreinem albumin und zur depyrogenierung albuminhaltiger ausgangssubstanzen |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2556733C3 (de) * | 1975-12-17 | 1986-10-02 | Armour Pharma GmbH & Co KG, 3440 Eschwege | Verfahren zum Isolieren von Albumin aus Blutplasma |
| DK25877A (da) * | 1977-01-21 | 1978-08-15 | Nordisk Insulinlab | Fremgangsmaade til udvinding af renset albumin fra blodplasma |
| HUT40311A (en) * | 1983-06-03 | 1986-12-28 | Kiskunhalasi Aag | Process for producing protein concentrates, blood-curd and nutriments from blood and its elements |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2190437B1 (nl) * | 1972-07-05 | 1975-08-08 | Merieux Inst |
-
1974
- 1974-03-28 DE DE2415079A patent/DE2415079C3/de not_active Expired
-
1975
- 1975-03-17 NL NLAANVRAGE7503132,A patent/NL177886C/nl not_active IP Right Cessation
- 1975-03-18 SE SE7503075A patent/SE436649B/xx not_active IP Right Cessation
- 1975-03-21 GB GB12045/75A patent/GB1480184A/en not_active Expired
- 1975-03-24 ZA ZA00751827A patent/ZA751827B/xx unknown
- 1975-03-24 FR FR7509054A patent/FR2265757B1/fr not_active Expired
- 1975-03-24 BE BE154638A patent/BE827050A/nl not_active IP Right Cessation
- 1975-03-25 DK DK125275A patent/DK141523C/da not_active IP Right Cessation
- 1975-03-26 DD DD185043A patent/DD119248A5/xx unknown
- 1975-03-26 EG EG169A patent/EG11782A/xx active
- 1975-03-27 CH CH400275A patent/CH629819A5/de not_active IP Right Cessation
- 1975-03-27 AT AT238175A patent/AT338977B/de not_active IP Right Cessation
- 1975-03-27 ES ES436125A patent/ES436125A1/es not_active Expired
- 1975-03-27 PL PL1975179122A patent/PL93587B1/pl unknown
- 1975-03-28 SU SU752117933A patent/SU743564A3/ru active
- 1975-03-28 JP JP3771375A patent/JPS5418325B2/ja not_active Expired
- 1975-04-07 IN IN691/CAL/1975A patent/IN140388B/en unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3307871A1 (de) * | 1983-03-05 | 1984-09-13 | R & Z Biologicals S.A. (Pty.) Ltd., Cape Town | Verfahren zur gewinnung von hochreinem albumin und zur depyrogenierung albuminhaltiger ausgangssubstanzen |
Also Published As
| Publication number | Publication date |
|---|---|
| DK125275A (nl) | 1975-09-29 |
| DK141523B (da) | 1980-04-14 |
| ATA238175A (de) | 1977-01-15 |
| DE2415079C3 (de) | 1980-02-14 |
| EG11782A (en) | 1978-03-29 |
| AT338977B (de) | 1977-09-26 |
| NL177886C (nl) | 1985-12-16 |
| SE436649B (sv) | 1985-01-14 |
| FR2265757B1 (nl) | 1979-03-02 |
| NL177886B (nl) | 1985-07-16 |
| NL7503132A (nl) | 1975-09-30 |
| DK141523C (da) | 1980-09-29 |
| IN140388B (nl) | 1976-10-30 |
| SU743564A3 (ru) | 1980-06-25 |
| FR2265757A1 (nl) | 1975-10-24 |
| GB1480184A (en) | 1977-07-20 |
| DD119248A5 (nl) | 1976-04-12 |
| BE827050A (nl) | 1975-07-16 |
| ZA751827B (en) | 1976-02-25 |
| JPS50154413A (nl) | 1975-12-12 |
| AU7947475A (en) | 1976-09-30 |
| DE2415079B2 (de) | 1979-06-21 |
| DE2415079A1 (de) | 1975-10-02 |
| SE7503075L (nl) | 1975-09-29 |
| PL93587B1 (nl) | 1977-06-30 |
| JPS5418325B2 (nl) | 1979-07-06 |
| ES436125A1 (es) | 1977-01-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69127384T3 (de) | Verfahren zur Reinigung von Immunserumglobulinen | |
| DE2801123C2 (de) | Verfahren zur Herstellung eines intravenös applizierbaren Serumeiweiß-Präparates | |
| CH633020A5 (de) | Verfahren zum gewinnen gereinigten albumins aus blutplasma. | |
| DE2459291B2 (de) | Verfahren zur Herstellung eines antihämophiles Globulin A enthaltenden Konzentrats neben einem Prothrom-bin-Komplex und einer Lösung von lagerstabilen Serumproteinen | |
| DE2127159A1 (de) | Verfahren zur Fraktionierung von Plasmaproteinen | |
| DE2433209A1 (de) | Hitzestabile plasmaproteinloesungen, verfahren zu ihrer herstellung und arzneipraeparate | |
| DE69133399T2 (de) | Methode zur Herstellung von im Wesentlichen monomeren normalen menschlichen Serum-Albumin | |
| AT403989B (de) | Verfahren zur herstellung eines plasmaprotein-hältigen arzneimittels | |
| DE2403994A1 (de) | Herstellung von antisera | |
| DE2732998C2 (de) | Verfahren zur Herstellung von Serumalbuminfraktionen | |
| DD296842A5 (de) | Verfahren zur herstellung von gereinigten albuminloesungen | |
| DE2734150C3 (de) | Verfahren zur Herstellung von Human-Lysozympräparaten | |
| CH633809A5 (de) | Verfahren zur herstellung einer serumalbuminfraktion. | |
| DE2415079C3 (de) | Verfahren zum Isolieren von Albumin aus Blutplasma | |
| DE3344656A1 (de) | Verfahren zur herstellung einer serumproteinloesung | |
| DE2440926C3 (de) | Injizierbarer inaktivierter Impfstoff gegen Hepatitis B und Verfahren zu seiner Herstellung | |
| DE3307871C2 (de) | Verfahren zur Gewinnung von hochreinem Albumin | |
| AT367297B (de) | Verfahren zur herstellung eines serumeiweiss-pr[parates | |
| DE2856939A1 (de) | Verfahren zur gewinnung von intravenoes-vertraeglichen gammaglobulinen | |
| AT271725B (de) | Verfahren zur Gewinnung von Gammaglobulin | |
| AT208507B (de) | Verfahren zur Herstellung einer stabilen hitzeinaktivierbaren Proteinlösung | |
| DE2733923A1 (de) | Verfahren zur gewinnung von humanalbumin | |
| DE2532276C3 (de) | Verfahren zur Reinigung von Human-Antilymphozytenserum | |
| CH526961A (de) | Verfahren zur Herstellung einer stabilen Lösung der Albumin und a- und B-Globulinfraktion des Blutplasmas bzw. Blutserums | |
| DE1130113B (de) | Verfahren zur Abtrennung von therapeutisch verwendbaren, mindestens 80% ª†-Globulin enthaltenden Praeparaten von anderen Blutproteinen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased | ||
| PL | Patent ceased |